[Strongyloidiasis in the immunocompromised patient].
D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D013322:Strongyloidiasis / Q000150:complications* / Q000188:drug therapy; D013827:Thiabendazole / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D013827:Thiabendazole
Estrongiloidiasis en el paciente inmunocomprometido.